81 related articles for article (PubMed ID: 15109276)
21. The Role and Effectiveness of Photodynamic Therapy on Patients With Actinic Keratosis: A Systematic Review and Meta-Analysis.
Mpourazanis G; Konschake W; Vogiatzis R; Papalexis P; Georgakopoulou VE; Ntritsos G; Sklapani P; Trakas N
Cureus; 2022 Jun; 14(6):e26390. PubMed ID: 35911353
[TBL] [Abstract][Full Text] [Related]
22. Photodynamic Therapy for Basal Cell Carcinoma: The Clinical Context for Future Research Priorities.
Collier NJ; Rhodes LE
Molecules; 2020 Nov; 25(22):. PubMed ID: 33218174
[TBL] [Abstract][Full Text] [Related]
23. Interventions for basal cell carcinoma of the skin.
Thomson J; Hogan S; Leonardi-Bee J; Williams HC; Bath-Hextall FJ
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD003412. PubMed ID: 33202063
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of photodynamic therapy with amino-5-laevulinate nanoemulsion versus methyl-5-aminolaevulinate for actinic keratosis: A meta-analysis.
Fu C; Kuang BH; Qin L; Zeng XY; Wang BC
Photodiagnosis Photodyn Ther; 2019 Sep; 27():408-414. PubMed ID: 31310826
[TBL] [Abstract][Full Text] [Related]
25. A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy.
Morton CA; Dominicus R; Radny P; Dirschka T; Hauschild A; Reinhold U; Aschoff R; Ulrich M; Keohane S; Ekanayake-Bohlig S; Ibbotson S; Ostendorf R; Berking C; Gröne D; Schulze HJ; Ockenfels HM; Jasnoch V; Kurzen H; Sebastian M; Stege H; Staubach P; Gupta G; Hübinger F; Ziabreva I; Schmitz B; Gertzmann A; Lübbert H; Szeimies RM
Br J Dermatol; 2018 Aug; 179(2):309-319. PubMed ID: 29432644
[TBL] [Abstract][Full Text] [Related]
26. Photodynamic Therapy: A Clinical Consensus Guide.
Ozog DM; Rkein AM; Fabi SG; Gold MH; Goldman MP; Lowe NJ; Martin GM; Munavalli GS
Dermatol Surg; 2016 Jul; 42(7):804-27. PubMed ID: 27336945
[TBL] [Abstract][Full Text] [Related]
27. Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities.
Kaufmann R; Spelman L; Weightman W; Reifenberger J; Szeimies RM; Verhaeghe E; Kerrouche N; Sorba V; Villemagne H; Rhodes LE
Br J Dermatol; 2008 May; 158(5):994-9. PubMed ID: 18341663
[TBL] [Abstract][Full Text] [Related]
28. Aminolevulinic acid photodynamic therapy for actinic keratoses/actinic cheilitis/acne: vascular lasers.
Alexiades-Armenakas M
Dermatol Clin; 2007 Jan; 25(1):25-33. PubMed ID: 17126739
[TBL] [Abstract][Full Text] [Related]
29. 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy.
Howley R; Chandratre S; Chen B
Bioengineering (Basel); 2023 Apr; 10(4):. PubMed ID: 37106683
[TBL] [Abstract][Full Text] [Related]
30. Clinical efficacy of methyl aminolevulinate (Metvix) photodynamic therapy.
Foley P
J Dermatolog Treat; 2003; 14 Suppl 3():15-22. PubMed ID: 14522637
[TBL] [Abstract][Full Text] [Related]
31. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer.
Lehmann P
Br J Dermatol; 2007 May; 156(5):793-801. PubMed ID: 17419691
[TBL] [Abstract][Full Text] [Related]
32. Topical methyl aminolevulinate.
Siddiqui MA; Perry CM; Scott LJ
Am J Clin Dermatol; 2004; 5(2):127-37; discussion 138-40. PubMed ID: 15109276
[TBL] [Abstract][Full Text] [Related]
33. Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma.
Annemans L; Caekelbergh K; Roelandts R; Boonen H; Leys C; Nikkels AF; van Den Haute V; van Quickenborne L; Verhaeghe E; Leroy B
Eur J Dermatol; 2008; 18(5):539-46. PubMed ID: 18693157
[TBL] [Abstract][Full Text] [Related]
34. Economic evaluation of methyl aminolaevulinate-based photodynamic therapy in the management of actinic keratosis and basal cell carcinoma.
Caekelbergh K; Annemans L; Lambert J; Roelandts R
Br J Dermatol; 2006 Oct; 155(4):784-90. PubMed ID: 16965429
[TBL] [Abstract][Full Text] [Related]
35. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment.
Horn M; Wolf P; Wulf HC; Warloe T; Fritsch C; Rhodes LE; Kaufmann R; De Rie M; Legat FJ; Stender IM; Solér AM; Wennberg AM; Wong GA; Larkö O
Br J Dermatol; 2003 Dec; 149(6):1242-9. PubMed ID: 14674903
[TBL] [Abstract][Full Text] [Related]
36. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial.
Rhodes LE; de Rie M; Enström Y; Groves R; Morken T; Goulden V; Wong GA; Grob JJ; Varma S; Wolf P
Arch Dermatol; 2004 Jan; 140(1):17-23. PubMed ID: 14732655
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
